A detailed history of Advisory Resource Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisory Resource Group holds 12,143 shares of AZN stock, worth $796,945. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,143
Holding current value
$796,945
% of portfolio
0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$76.67 - $87.62 $931,003 - $1.06 Million
12,143 New
12,143 $946,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Advisory Resource Group Portfolio

Follow Advisory Resource Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Resource Group with notifications on news.